... allograft recipients. The vertical lines represent the range of total observations. Profiles of patients in the belatacept group (n = 3) at weeks 1, 2 and 13 (A, B and C) and the cyclosporine group ... the range of total observations. Profiles of patients in the belatacept group (n = 3) at weeks 1, 2 and 13 (A, B and C) and the cyclosporine group (n = 3) at weeks 1, 2 and 13 (D, E and F).60801001201401601802002200246810IMPDH1 ... design of the study. PFJ, HH, KM and JS provided the patients. The samples were collected by JS. SB, NTV, HR and StB con-tributed to the development of analytical methods. SB and NTV prepared the...